×

Driving patient compliance with therapy

  • US 9,828,624 B2
  • Filed: 07/24/2013
  • Issued: 11/28/2017
  • Est. Priority Date: 07/24/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method for determining a patient'"'"'s compliance with a cholesterol lowering therapy and treating the patient, the method comprising:

  • conducting a first assay to determine a level of a cholesterol absorption sterol and a level of a cholesterol production sterol in a first sample obtained from a patient prior to undergoing a cholesterol lowering therapy;

    comparing the level of the cholesterol absorption sterol against the level of the cholesterol production sterol to classify the patient as a balanced producer, an over producer, or an over-absorber of cholesterol;

    conducting a second assay to determine a cholesterol level in a second sample obtained from the patient after the patient has started undergoing the cholesterol lowering therapy;

    identifying the patient as non-compliant with the cholesterol lowering therapy when the patient'"'"'s cholesterol level has not decreased as expected compared to a prior cholesterol level taken from the patent before undergoing the cholesterol lowering therapy and given the patient'"'"'s classification; and

    administering an alternative therapy to the patient in response to identifying the patient as non-compliant with the cholesterol lowering therapy.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×